scPharmaceuticals Inc (SCPH)
4.41
+0.16
(+3.76%)
USD |
NASDAQ |
Jul 05, 16:00
4.41
0.00 (0.00%)
After-Hours: 20:00
scPharmaceuticals Research and Development Expense (Annual): 11.81M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.81M |
| December 31, 2022 | 15.53M |
| December 31, 2021 | 16.04M |
| December 31, 2020 | 18.15M |
| December 31, 2019 | 24.63M |
| Date | Value |
|---|---|
| December 31, 2018 | 15.95M |
| December 31, 2017 | 14.33M |
| December 31, 2016 | 11.86M |
| December 31, 2015 | 8.267M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
11.81M
Minimum
2023
24.63M
Maximum
2019
17.23M
Average
16.04M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Vigil Neuroscience Inc | 60.93M |
| NovaBay Pharmaceuticals Inc | 0.068M |
| Palatin Technologies Inc | 22.63M |
| iBio Inc | 10.33M |
| Theriva Biologics Inc | 14.31M |